Protective effects of hyperbaric oxygen therapy (HBO2) in cardiac care--A proposal to conduct a study into the effects of hyperbaric pre-conditioning in elective coronary artery bypass graft surgery (CABG)

What Researchers Did

Researchers reviewed existing data on the benefits of hyperbaric oxygen therapy (HBO2) as a preconditioning treatment for patients undergoing elective coronary artery bypass graft (CABG) surgery.

What They Found

The review found that hyperbaric oxygen therapy (HBO2) preconditioning in elective CABG patients improved myocardial function, reduced intensive care unit (ICU) length of stay, and limited post-surgical complications. This approach demonstrated both clinical and cost benefits by mitigating ischaemia-reperfusion injury.

Canadian Relevance

This review does not have a direct Canadian connection, as the studies discussed were conducted outside of Canada and the United States.

Study Limitations

As a review, this study synthesizes existing evidence rather than presenting new primary research data, and it serves as a proposal for future investigation.